Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine

Abstract : The development of an effective, affordable prophylactic vaccine against hepatitis C virus (HCV) remains a medical priority. The recently described chimeric HBV-HCV subviral envelope particles could potentially be used for this purpose, as they could be produced by industrial procedures adapted from those established for the hepatitis B virus (HBV) vaccine. We show here, in an animal model, that pre-existing immunity acquired through HBV vaccination does not influence the immunogenicity of the HCV E2 protein presented by these chimeric particles. Thus, these chimeric HBV-HCV subviral envelope particles could potentially be used as a booster in individuals previously vaccinated against HBV, to induce protective immunity to HCV.
Type de document :
Article dans une revue
Vaccine, Elsevier, 2015, 33, pp.973 - 976. 〈10.1016/j.vaccine.2015.01.007〉
Liste complète des métadonnées

Littérature citée [17 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01575077
Contributeur : Philippe Roingeard <>
Soumis le : jeudi 17 août 2017 - 17:11:19
Dernière modification le : mercredi 21 mars 2018 - 10:54:08

Fichiers

Vaccine_2015.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Elodie Beaumont, Philippe Roingeard. Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine. Vaccine, Elsevier, 2015, 33, pp.973 - 976. 〈10.1016/j.vaccine.2015.01.007〉. 〈inserm-01575077〉

Partager

Métriques

Consultations de la notice

114

Téléchargements de fichiers

57